M&A · Healthcare · Buyer's industry: Laboratory Analytical Instruments
PerkinElmer Inc to acquire BioLegend
Announced Jul 26, 2021 · Closed Sep 21, 2021 · Private target
Deal value$5.25B
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationCash and stock
Transaction
- Acquirer
- PerkinElmer Inc (PKI)
- Target
- BioLegend
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Sep 21, 2021
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Goldman Sachs
- To the target
- JPMorgan
Classification
- Sector
- Healthcare
- Buyer's industry
- Laboratory Analytical Instruments